Mancini Marianna

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mancini Marianna's trades of Viking Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
71.39
Quantity 60,347
Value US$4,299,594
Transaction date
Proposed sale
Price
35.00
Quantity 6,185
Value US$216,492
Transaction date
Proposed sale
Price
27.77
Quantity 4,266
Value US$118,473
Transaction date
Proposed sale
Price
42.75
Quantity 54,215
Value US$2,317,599
Transaction date
Proposed sale
Price
57.13
Quantity 18,026
Value US$1,029,888
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-29
S Sale
53,723 +23.8%
157.27
US$4,069,167 		53,723 +23.8% 157.27 US$4,069,167
2026-07-29 2026-07-29
PrS Proposed sale
70,640
365.17
US$3,970,055 		70,640 365.17 US$3,970,055
2026-01-05 2026-01-05
PrS Proposed sale
60,347
71.39
US$4,299,594 		60,347 71.39 US$4,299,594
2026-01-05 2026-01-05
S Sale
1,600 -0.4%
35.07
US$56,117 		1,600 -0.4% 35.07 US$56,117
2026-01-05 2026-01-05
S Sale
10,500 -2.5%
34.22
US$359,303 		10,500 -2.5% 34.22 US$359,303
2026-01-05 2026-01-05
S Sale
13,600 -3.1%
33.37
US$453,876 		13,600 -3.1% 33.37 US$453,876
2026-01-05 2026-01-05
S Sale
31,961 -6.8%
32.29
US$1,032,110 		31,961 -6.8% 32.29 US$1,032,110
2025-10-28 2025-10-28
PrS Proposed sale
6,185
35.00
US$216,492 		6,185 35.00 US$216,492
2025-10-28 2025-10-28
S Sale
6,185 -1.6%
35.00
US$216,492 		6,185 -1.6% 35.00 US$216,492
2025-07-03 2025-07-03
PrS Proposed sale
4,266
27.77
US$118,473 		4,266 27.77 US$118,473
2025-07-03 2025-07-03
S Sale
4,266 -1.1%
27.77
US$118,473 		4,266 -1.1% 27.77 US$118,473
2025-01-06 2025-01-06
PrS Proposed sale
54,215
42.75
US$2,317,599 		54,215 42.75 US$2,317,599
2025-01-06 2025-01-06
S Sale
5,100 -1.3%
43.32
US$220,914 		5,100 -1.3% 43.32 US$220,914
2025-01-06 2025-01-06
S Sale
49,115 -11.5%
42.69
US$2,096,685 		49,115 -11.5% 42.69 US$2,096,685
2024-07-31 2024-07-30
S Sale
3,322 -0.9%
57.82
US$192,078 		3,322 -0.9% 57.82 US$192,078
2024-07-31 2024-07-30
S Sale
14,704 -3.9%
56.98
US$837,834 		14,704 -3.9% 56.98 US$837,834
2024-07-30 2024-07-30
PrS Proposed sale
18,026
57.13
US$1,029,888 		18,026 57.13 US$1,029,888
2024-05-02 2024-05-01
PlS Planned sale
6,248 -1.8%
80.08
US$500,310 		6,248 -1.8% 80.08 US$500,310
2024-05-02 2024-05-01
PlS Planned sale
119,946 -25.3%
79.29
US$9,511,058 		119,946 -25.3% 79.29 US$9,511,058
2024-05-02 2024-05-01
PlS Planned sale
105,343 -18.2%
78.65
US$8,284,974 		105,343 -18.2% 78.65 US$8,284,974
2024-05-02 2024-05-01
PlS Planned sale
26,142 -4.3%
77.49
US$2,025,830 		26,142 -4.3% 77.49 US$2,025,830
2024-05-02 2024-05-01
PlS Planned sale
23,746 -3.8%
76.40
US$1,814,301 		23,746 -3.8% 76.40 US$1,814,301
2024-05-01 2024-05-01
PrS Proposed sale
281,425
0.00
US$79 		281,425 0.00 US$79
2023-04-18 2023-04-17
PlS Planned sale
12,500 -4.2%
20.00
US$250,000 		12,500 -4.2% 20.00 US$250,000
2023-04-17 2023-04-17
PrS Proposed sale
12,500
20.00
US$250,000 		12,500 20.00 US$250,000
2023-03-30 2023-03-29
PlS Planned sale
41,242 -13.6%
16.00
US$659,872 		41,242 -13.6% 16.00 US$659,872
2023-03-30 2023-03-28
PlS Planned sale
196,563 -40.6%
15.00
US$2,948,445 		196,563 -40.6% 15.00 US$2,948,445